Background:
This study aimed to investigate the effects of psychological nursing care (PNC) on anxiety relief in perioperative lung cancer (LC) patients.
Methods:
We searched the Cochrane Library, PubMed, Embase, CNKI, CBM, and Wangfang electronic databases from inception to May 1, 2022. Eligible randomized controlled trials (RCTs) investigating the effects and safety of PNC on anxiety relief in perioperative LC patients. Anxiety was the primary outcome measure. The secondary outcomes were depression, length of hospital stay, and the occurrence of adverse events.
Results:
Six eligible RCTs with 494 patients were included in this study. Compared with routine nursing care, PNC showed better outcomes in terms of anxiety relief (mean difference [MD] = –13.24; random 95% confidence interval (CI), –18.28 to –8.20; P<.001), depression decrease (MD = –11.84; random 95% CI, –18.67 to –5.01; P < .001), and length of hospital stay (MD = –2.6; fixed 95% CI, –3.13 to –2.07; P < .001). No data on adverse events were pooled because only 1 trial reported this outcome.
Conclusions:
This study showed that PNC may benefit more than routine nursing care for patients with LC in anxiety, depression, and length of hospital stay. High-quality RCTs are needed to validate the current findings in the future.
Keywords: anxiety, depression, lung cancer, meta-analysis, psychological nursing care, systematic review
1. Introduction
Lung cancer (LC) is one of the most common cancers and a leading cause of cancer-related mortality in China and worldwide.[1–4] LC mainly consists of non–small cell lung cancer and small cell LC,[5–8] and non–small cell lung cancer accounts for over 83% of all LC cases.[9] Studies have reported that its incidence has increased significantly and is likely to show an upward trend over the next few decades.[10–15] There were 2,206,771 new LC patients and 1,796,144 LC mortality in 2020.[4] Of those, most patients with LC have a limited life span.
Various modalities have been reported to treat such disorders, including surgical resection, chemotherapy, radiotherapy, targeted management, and alternative therapy, especially surgery.[16–24] Although an increasing number of patients with LC benefit from surgery, they experience uncomfortable disorders such as physical function, quality of life, anxiety, depression, and adverse events (AEs).[25–29] Based on routine nursing care (RNC), including health education and guidance of medication and diet, psychological nursing care (PNC) refers to cognitive, emotional, and behavioral interventions. Cognitive intervention focused on improving patients’ understanding of LC and cognitive level with detailed knowledge instruction of LC, such as their personalized situation and possible occurrence during the perioperative period. Emotional intervention aimed to instruct individual psychological guidance according to the specific conditions of the patients. Behavioral intervention was to guide the patients to take positive actions to deal with the possible stress reaction caused by LC, such as guidance to patients on how to deal with emotions, progressive muscle relaxation, and deep breathing training.
Previous clinical studies have explored the effects of PNC on anxiety and depression relief in perioperative LC.[30–35] However, no systematic review and meta-analysis has addressed this issue. Thus, this systematic review and meta-analysis comprehensively investigated the effects and safety of PNC on anxiety and depression relief in LC patients during perioperative period.
2. Methods
2.1. Ethical approval
This systematic review and meta-analysis did not need ethical approval because it analyzed secondary data from patient records and did not involve any individual patient data.
2.2. Literature search
This study conducted a comprehensive literature search of the Cochrane Library, PubMed, Embase, CNKI, CBM, and Wangfang from inception to May 1, 2022. All potential randomized controlled trials (RCTs) focusing on the effects and safety of PNC on anxiety and depression relief in perioperative patients with LC were included in the analysis. In addition, we searched other literature sources, such as dissertations and reference lists of related reviews. We utilized the keywords of “lung cancer”, “lung neoplasms”, “pulmonary neoplasms”, “pulmonary cancer”, “anxiety”, “depression”, “emotion”, “pressure”, “psychological disorder”, “surgery”, “surgical resection”, “nursing care”, “psychological care”, “randomized controlled trial”, “clinical trial”, and “controlled study”.
2.3. Study selection
Two authors independently performed study selection in accordance with the eligibility criteria. First, duplicate literature was eliminated from all records. After removing duplicates, we identified titles/abstracts, and all irrelevant studies were excluded. Finally, the full text of potential articles was carefully read against the eligibility criteria. We resolved any divergence with the help of a third experienced author.
2.4. Eligibility criteria
2.4.1. Inclusion criteria.
The inclusion criteria were as follow: only RCTs of PNC on anxiety relief in patients with LC during the perioperative period; all patients were diagnosed with LC and underwent surgery for anxiety; and patients in the experimental group underwent PNC, whereas those in the control group received RNC.
2.4.2. Exclusion criteria.
The exclusion criteria were as follows: duplicate, irrelevant studies, such as reviews, case studies, and uncontrolled studies; and studies not involving PNC, not RCT, combined therapy, and insufficient data and information.
2.5. Outcome measurements
The primary outcome were anxiety and depression. Anxiety was measured using related scales, such as the self-rating anxiety scale (SAS) and Hamilton Anxiety Scale (HAMA).[36,37] Depression was assessed using any associated tool, such as the self-rating depression scale (SDS) and Hamilton Depression Scale (HAMD).[38,39] SAS consists of 20 items, and each one ranges from 1 to 4, with a higher score indicating more serious anxiety.[36] HAMA includes 14 subscale, and each subscale varies from 0 to 4, with a higher score suggesting more serious symptoms.[37] SDS also comprises 20 items.[38] Each item scores from 1 to 4, with a higher score signifying more serious anxiety.[38] HAMA has 17 items. Each one ranges from 0 to 4, with a higher score meaning more serious conditions.[39] Secondary outcomes were length of hospital stay (LHS) and the occurrence rate of AEs.
2.6. Data extraction
Two authors independently extracted data from all the included trials. It comprised the following information: title, first author, time of publication, age, sample size, types and details of experimental and control modalities, primary and secondary outcomes, and AEs. We resolved any conflicts between the 2 authors by a third experienced author through a discussion.
2.7. Risk-of-bias assessment
This study used the Cochrane risk-of-bias tool to assess methodological quality of each trial.[40] This tool covers 7 fields, each of which is rated as high, unclear, or low risk of bias. Any disagreement was resolved by a third experienced author through discussion.
2.8. Statistical analysis
This study performed all data analyses using RevMan 5.3 software. All continuous data were calculated using the mean difference (MD) and 95% confidence interval (CI), and all dichotomous data were presented as odds ratios and 95% CI. I² test was performed to investigate the heterogeneity of pooled data. We used a fixed-effects model to pool data when I² <50%. Otherwise, we utilized a random-effects model to synthesize the data if I² was ≥50%.
3. Results
3.1. Search results
After a comprehensive search, 597 records were identified after duplicates were removed (Fig. 1). We eliminated 552 irrelevant records, and 45 full-text articles were carefully read. We further excluded 39 articles because they did not involve PNC, incomplete data, combined therapy, and were not RCT. Finally, we included 6 studies for qualitative synthesis and 5 studies for quantitative synthesis (meta-analysis; Fig. 1).
Figure 1.
Flow diagram of study selection. RCT = randomized controlled trial.
3.2. Study characteristics
This study included 6 eligible trials with a total of 494 patients. All 6 eligible trials investigated the comparative outcomes between PNC and RNC. The general characteristics of the patients from all 6 studies are summarized in Table 1.
Table 1.
General characteristics of included studies.
| Study |
No. of patients (T/C) |
Age (yr, T/C) | Intervention | Control | Outcomes |
|---|---|---|---|---|---|
| Chen et al[30] | 30/30 | T: 59.9 ± 2.4 C: 59.7 ± 2.2 |
PNC | RNC | SAS; SDS; LHS |
| Chen et al[31] | 40/40 | T: 55.2 ± 10.7 C: 55.3 ± 10.7 |
PNC | RNC | HAMA; HAMD |
| Gao et al[32] | 60/60 | T: NR C: NR |
PNC | RNC | SAS |
| Li et al[33] | 33/33 | T: 52.9 ± 1.5 C: 52.6 ± 1.4 |
PNC | RNC | SAS; SDS; AEs |
| Liu et al[34] | 44/44 | T: NR C: NR |
PNC | RNC | SAS; SDS |
| Liu et al[35] | 40/40 | T: 60.2 ± 2.5 C: 60.2 ± 2.5 |
PNC | RNC | SAS; LHS |
AE = adverse event, C = control group, HAMA = Hamilton Anxiety Scale, HAMD = Hamilton Depression Scale, LHS, = length of hospital stay, NR = not reported, PNC = psychological nursing care, RNC = routine nursing care, SAS = self-rating anxiety scale, SDS = self-rating depression scale, T = treatment group.
3.3. Study quality assessment
The methodological quality of the 6 included RCTs was assessed using the Cochrane risk-of-bias tool[30–35] (Fig. 2). All 6 studies reported random sequence generation, details of incomplete outcome data, selective reporting, and other bias.[30–35] However, all of them failed to clearly report the allocation concealment and blinding of participants, investigators, and outcome assessors.[30–35]
Figure 2.
Risk-of-bias summary.
3.4. Pooled analysis of anxiety
Five studies with 414 patients investigated the effects of PNC vs RNC on anxiety relief using SAS. There were statistically significant differences in anxiety relief (MD = –13.24; random 95% CI, –18.28 to –8.20; P < .001; I² = 95%; Table 2, Fig. 3). Another study involving 80 patients explored the effects of PNC vs RNC on anxiety relief using HAMA (MD = –4.4; fixed 95% CI, –5.4 to –3.4; Table 2).
Table 2.
Qualitative synthesis of included studies.
| Outcome or subgroup | Studies | Participants | Statistical method | Effect estimate |
|---|---|---|---|---|
| 1.1 SAS | 5 | 414 | Mean difference (IV, random, 95% CI) | –13.24 (–18.28 to –8.20) |
| 1.2 SDS | 3 | 214 | Mean difference (IV, random, 95% CI) | –11.84 (–18.67 to –5.01) |
| 1.3 LHS | 2 | 140 | Mean difference (IV, fixed, 95% CI) | –2.60 (–3.13 to –2.07) |
| 1.4 HAMA | 1 | 80 | Mean difference (IV, fixed, 95% CI) | –4.40 (–5.40 to –3.40) |
| 1.5 HAMD | 1 | 80 | Mean difference (IV, fixed, 95% CI) | –3.40 (–6.13 to –0.67) |
| 1.6 AEs | 1 | 66 | Odds ratio (M-H, fixed, 95% CI) | 0.14 (0.02–1.24) |
AE = adverse events, CI = confidence interval, HAMA = Hamilton Anxiety Scale, HAMD, Hamilton Depression Scale, M-H = Mantel-Haenszel, LHS = length of hospital stay, SAS = self-rating anxiety scale, SDS = self-rating depression scale.
Figure 3.
Meta-analysis of anxiety. CI = confidence interval, SD = standard deviation.
3.5. Pooled analysis of depression
Three studies with 214 participants explored the effects of PNC vs RNC on depression. Statistically significant differences were identified between the 2 modalities of PNC and RNC for depression (MD = –11.84; random 95% CI, –18.67 to –5.01; P < .001; I² = 95%; Table 2, Fig. 4). Another study of 80 patients investigated the effects of PNC vs RNC on depression using the HAMD (MD = –3.4; fixed 95% CI, –6.13 to –0.67; Table 2).
Figure 4.
Meta-analysis of depression. CI = confidence interval, SD = standard deviation.
3.6. Pooled analysis of LHS
Two eligible trials with 140 subjects assessed the effects of PNC vs RNC on the LHS. There were significant differences in the LHS (MD = –2.6; fixed 95% CI, –3.13 to –2.07; P < .001; I² = 0%; Table 2, Fig. 5).
Figure 5.
Meta-analysis of length of hospital stay. CI = confidence interval, SD = standard deviation.
3.7. AEs report
One study of 66 patients explored the effects of PNC vs RNC on AEs (MD = 0.14; fixed 95% CI, 0.02–1.24; Table 2).
4. Discussion
LC has become one of the most malignant neoplasms globally, with approximately 2.2 million new cases and 1.8 million cancer-related deaths annually. It also ranks as one of the highest morbidity rates worldwide for both males and females.[41,42] A previous study reported that it accounted for approximately 11.4% of all cancers in 2020.[42] Therefore, effective treatment modalities are very important for the management of this condition.
Surgical resection is the most effective treatment option. However, patients with LC who undergo surgery also have a variety of uncomfortable experiences, such as psychological disorders including anxiety, depression, and AEs.[25–29] Previous clinical studies reported that PNC was effective for the management of psychological disorders, including anxiety and depression, in patients with LC during the perioperative period.[30–35] However, no systematic review and meta-analysis focused on investigation of PNC comparing with RNC for the treatment of LC patients with depression and anxiety during the perioperative period. The present study comprehensively explored this topic.
In this study, a total of 597 studies were searched, and we finally included 6 studies involving 494 patients. We pooled the outcome data for anxiety, depression, and LHS. There were statistically significant differences between the PNC and RNC groups in anxiety, depression, and LHS. The findings show that the effects of PNC are superior to RNC in relieving anxiety and depression and LHS reduction. Regarding AEs, only 1 study reported this outcome; thus, no data on AEs were pooled in this study.
This systematic review and meta-analysis has several limitations. First, this study included only 6 eligible trials, which may affect the present findings. Second, all studies failed to clearly report the blinding details of patients, researchers, and outcome assessors, which may impact the risk of selection, performance, and detection bias. Third, the sample size of all included studies was quite small, which may affect the current results. Fourth, the overall methodological quality of all included studies is not high. Finally, all studies were conducted in China and they were published in Chinese academic journals. Thus, more high-quality eligible RCTs are required to validate the present findings.
5. Conclusion
This study showed that PNC was superior to RNC in relieving anxiety and depression, as well as reducing the LHS in patients with LC during the perioperative period. Future similar studies involving high-quality RCTs are needed to confirm the present findings.
Author contributions
Conceptualization: Ren-Ying Zhu and Jiu-Ying Wang.
Data curation: Ren-Ying Zhu and Hong Chen .
Formal analysis: Yue-Juan Gao.
Investigation: Jiu-Ying Wang.
Methodology: Yue-Juan Gao.
Supervision: Jiu-Ying Wang.
Validation: Zhi-Han Pan.
Writing–original draft: Ren-Ying Zhu.
Writing–review & editing: Jiu-Ying Wang.
Abbreviations:
- AE =
- adverse event
- CI =
- confidence interval
- HAMA =
- Hamilton Anxiety Scale
- HAMD =
- Hamilton Depression Scale
- LC =
- lung cancer
- LHS =
- length of hospital stay
- MD =
- mean difference
- PNC =
- psychological nursing care
- RCT =
- randomized controlled trial
- RNC =
- routine nursing care
- SAS =
- self-rating anxiety scale
- SDS =
- self-rating depression scale
How to cite this article: Zhu R-Y, Chen H, Gao Y-J, Pan Z-H, Wang J-Y. Effects of psychological nursing care on anxiety and depression in perioperative patients with lung cancer: A systematic review and meta-analysis. Medicine 2022;101:29(e29914).
The authors have no conflicts of interest to disclose.
This study was supported by Research Project of Heilongjiang Health Commission (20210404130285).
The funder did not involve in any part of this study.
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Contributor Information
Ren-Ying Zhu, Email: lewhees350@21cn.com.
Hong Chen, Email: touguaizhiima@163.com.
Yue-Juan Gao, Email: huigou29368@163.com.
Zhi-Han Pan, Email: gouzajiu5c@163.com.
References
- [1].Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. [DOI] [PubMed] [Google Scholar]
- [2].Chen X, Mo S, Yi B. The spatiotemporal dynamics of lung cancer: 30-year trends of epidemiology across 204 countries and territories. BMC Public Health. 2022;22:987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3].Ye W, Lu W, Li X, et al. Long-term changes in the premature death rate in lung cancer in a developed region of China: population-based study. JMIR Public Health Surveill. 2022;8:e33633. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].Paci E, Puliti D, Lopes Pegna A, et al. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial. Thorax. 2017;72:825–31. [DOI] [PubMed] [Google Scholar]
- [5].Harrison S, Judd J, Chin S, et al. Disparities in lung cancer treatment. Curr Oncol Rep. 2022;24:241–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Zhu J, Yuan Y, Wan X, et al. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent. Cochrane Database Syst Rev. 2021;12:CD011300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Huang C, Yang X. Advances in biomarkers for immunotherapy of non-small cell lung cancer. Chin J Lung Cancer. 2021;24:777–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].Tian X, Gu T, Lee MH, et al. Challenge and countermeasures for EGFR targeted therapy in non-small cell lung cancer. Biochim Biophys Acta Rev Cancer. 2022;1877:188645. [DOI] [PubMed] [Google Scholar]
- [9].Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34. [DOI] [PubMed] [Google Scholar]
- [10].Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–32. [DOI] [PubMed] [Google Scholar]
- [11].Jakobsen E, Olsen KE, Bliddal M, et al. Forecasting lung cancer incidence, mortality, and prevalence to year 2030. BMC Cancer. 2021;21:985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [12].Ricotti A, Sciannameo V, Balzi W, et al. Incidence and prevalence analysis of non-small-cell and small-cell lung cancer using administrative data. Int J Environ Res Public Health. 2021;18:9076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].Chang S, Dai M, Ren JS, et al. Estimates and prediction on incidence, mortality and prevalence of lung cancer in China in 2008. Chin J Epidemiol. 2012;33:391–4. [PubMed] [Google Scholar]
- [14].Tian G, Bian L, Xu X, et al. Analysis on the incidence and economic burden of patients with lung cancer. Chin J Lung Cancer. 2022;25:167–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [15].Peng L, Qin BD, Xu S, et al. Risk and incidence of infection with bevacizumab in non-small-cell lung cancer patients: a meta-analysis. Oncol Res Treat. 2022;45:281–90. [DOI] [PubMed] [Google Scholar]
- [16].Kim D, Lee JW. Current status of lung cancer and surgery based on studies using a nationwide database. J Chest Surg. 2022;55:1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [17].Zhang T, Lu J, Fan Y, et al. Evidence-based nursing intervention can improve the treatment compliance, quality of life and self-efficacy of patients with lung cancer undergoing radiotherapy and chemotherapy. Am J Transl Res. 2022;14:396–405. [PMC free article] [PubMed] [Google Scholar]
- [18].Sereno M, Higuera O, Cruz Castellanos P, et al. Immunotherapy combinations and chemotherapy sparing schemes in first line non-small cell lung cancer. World J Clin Oncol. 2021;12:1182–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [19].Han JE, Hasan S, Choi JI, et al. Optimal surgical timing and radiotherapy dose for trimodality therapy in locally advanced non-small cell lung cancer. Cancer Med. 2021;10:5794–808. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [20].Hsu F, Sit D, Pastuch A, et al. Lung cancer epidermal growth factor receptor mutations and radiotherapy response: a multicentre clinical study. Clin Transl Radiat Oncol. 2021;30:15–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [21].Liu S, Meng Y, Liu L, et al. CD4+ T cells are required to improve the efficacy of CIK therapy in non-small cell lung cancer. Cell Death Dis. 2022;13:441. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22].Zhang L, Lin W, Tan F, et al. Sintilimab for the treatment of non-small cell lung cancer. Biomark Res. 2022;10:23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23].Li H, Liu H. Combined effects of acupuncture and auricular acupressure for relieving cancer-related fatigue in patients during lung cancer chemotherapy: a protocol for systematic review and meta-analysis. Medicine (Baltimore). 2021;100:e27502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [24].Kuang R, Xiong G, Lv W, et al. Efficacy and safety of acupuncture combined with analgesics on lung cancer pain: a protocol for systematic review and meta-analysis. Medicine (Baltimore). 2021;100:e26225. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [25].Wolff HB, Alberts L, Kastelijn EA, et al. Differences in longitudinal health utility between stereotactic body radiation therapy and surgery in stage I non-small cell lung cancer. J Thorac Oncol. 2018;13:689–98. [DOI] [PubMed] [Google Scholar]
- [26].Lu HB, Liu X, Wang YQ, et al. Active cycle of breathing technique: a respiratory modality to improve perioperative outcomes in patients with lung cancer. Clin J Oncol Nurs. 2022;26:176–82 [DOI] [PubMed] [Google Scholar]
- [27].Zhao L, Ma L, Chen X, et al. Psychological nursing intervention improve the mental health status of young patients with lung cancer surgery during the perioperative period. Medicine (Baltimore). 2021;100:e26736. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [28].Ma RC, Zhao Y, Liu X, et al. Multimodal exercise program: a pilot randomized trial for patients with lung cancer receiving surgical treatment. Clin J Oncol Nurs. 2021;25:E26–34. [DOI] [PubMed] [Google Scholar]
- [29].Zhao H, Ning J, Gu Y, et al. Consecutive severe immune-related adverse events after PD-1 inhibitor induction and surgery in locally advanced non-small cell lung cancer: a case report. Transl Lung Cancer Res. 2021;10:3682–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [30].Chen GF, Cheng QQ. Observation on the effect of psychological guidance in perioperative nursing care of patients with lung cancer. Electr J Integr Chin Western Med. 2019;7:114. [Google Scholar]
- [31].Chen YH, Li WH. Effect of perioperative individualized psychological nursing on preoperative anxiety and postoperative recovery of patients with lung cancer. Int J Psychiat. 2020;1:188–90. [Google Scholar]
- [32].Gao Y, Shi H, Chu S, et al. Effect of relaxation therapy of psychological nursing on patients with lung cancer during perioperative period. J Chifeng Coll (Natural Science Edition). 2017;33:28–30. [Google Scholar]
- [33].Li Y, Yi HM, Xiao Y. Application of high quality nursing in lung cancer radical operation. Modern Med Health. 2016;32:114–5. [Google Scholar]
- [34].Liu YH. Effect of psychological nursing intervention on perioperative mental health of elderly patients with lung cancer. Int J Nurs. 2015;34:676–8. [Google Scholar]
- [35].Liu J. Effect of perioperative individualized psychological nursing on preoperative anxiety and postoperative recovery of patients with lung cancer. J Psychol. 2021;16:119–20. [Google Scholar]
- [36].Ward CL, Flisher AJ, Zissis C, et al. Reliability of the beck depression inventory and the self-rating anxiety scale in a sample of South African adolescents. J Child Adolesc Ment Health. 2003;15:73–5. [DOI] [PubMed] [Google Scholar]
- [37].Maier W, Buller R, Philipp M., et al. The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord. 1988;14:61–8. [DOI] [PubMed] [Google Scholar]
- [38].Jokelainen J, Timonen M, Keinänen-Kiukaanniemi S, et al. Validation of the Zung self-rating depression scale (SDS) in older adults. Scand J Prim Health Care. 2019;37:353–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [39].Wang XM, Ma HY, Zhong J, et al. A Chinese adaptation of six items, self-report Hamilton Depression Scale: factor structure and psychometric properties. Asian J Psychiatr. 2022;73:103104. [DOI] [PubMed] [Google Scholar]
- [40].Minozzi S, Dwan K, Borrelli F, et al. Reliability of the revised Cochrane risk-of-bias tool for randomised trials (RoB2) improved with the use of implementation instruction. J Clin Epidemiol. 2022;141:99–105. [DOI] [PubMed] [Google Scholar]
- [41].Bade BC, Dela Cruz CS. Lung Cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. 2020;41:1–24. [DOI] [PubMed] [Google Scholar]
- [42].Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. [DOI] [PubMed] [Google Scholar]





